Bolt Biotherapeutics Inc.

AI Score

0

Unlock

0.46
-0.01 (-3.06%)
At close: Mar 03, 2025, 11:30 AM

Bolt Biotherapeutics Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Net Income -69.2M -88.1M -98.59M -60.73M -30.49M -11.59M
Depreciation & Amortization 1.85M 1.67M 1.19M 611K 335K 302K
Stock-Based Compensation 9.22M 9.58M 8.5M 1.42M 508K 123K
Other Working Capital -6.45M -5.83M 13.83M -5.17M 2.27M 1.14M
Other Non-Cash Items -1.54M 3.41M 8.56M 13.64M 1.04M 153K
Deferred Income Tax n/a n/a 2.76M 34K n/a n/a
Change in Working Capital -9.86M -3.06M 20.51M -2.28M 2.27M 1.14M
Operating Cash Flow -69.53M -76.5M -57.07M -47.31M -26.34M -9.87M
Capital Expenditures -206K -1.95M -2.34M -3.26M -508K -290K
Acquisitions n/a -59.81M 229.86M 17.33M n/a n/a
Purchase of Investments -164.99M -180.7M -313.38M -33.23M n/a n/a
Sales Maturities Of Investments 236.23M 240.52M 83.51M 15.9M n/a n/a
Other Investing Acitivies n/a 59.81M -229.86M -17.33M n/a n/a
Investing Cash Flow 71.04M 57.86M -232.2M -20.59M -508K -290K
Debt Repayment n/a n/a n/a n/a -40K -39K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a
Other Financial Acitivies n/a n/a 51.9M 39.3M 97.26M 38.25M
Financial Cash Flow 253K 503K 311.11M 39.6M 48.63M 19.09M
Net Cash Flow 1.77M -18.14M 21.84M -28.3M 21.78M 8.93M
Free Cash Flow -69.73M -78.46M -59.4M -50.57M -26.85M -10.16M